Release Date: 23/01/12 10:03 Summary: Quarterly Cashflow Report - AMENDED Price Sensitive: No Download Document 162.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%